Dr. Josephus-Ian Sanjorjo, MD

NPI: 1073808168
Total Payments
$5,622
2024 Payments
$1,297
Companies
23
Transactions
281
Medicare Patients
1,254
Medicare Billing
$663,705

Payment Breakdown by Category

Food & Beverage$5,376 (95.6%)
Other$200.00 (3.6%)
Education$45.42 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,376 275 95.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $200.00 1 3.6%
Education $45.42 5 0.8%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,568 66 $0 (2024)
Fresenius USA Marketing, Inc. $669.57 40 $0 (2024)
Amgen Inc. $514.64 24 $0 (2024)
Mallinckrodt Hospital Products Inc. $496.45 29 $0 (2024)
Relypsa, Inc. $446.08 43 $0 (2020)
Otsuka America Pharmaceutical, Inc. $274.49 9 $0 (2024)
Vifor Pharma, Inc. $253.80 4 $0 (2023)
CALLIDITAS THERAPEUTICS US INC. $238.92 14 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $178.99 10 $0 (2024)
AKEBIA THERAPEUTICS INC $142.12 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,297 65 AstraZeneca Pharmaceuticals LP ($431.66)
2023 $1,555 77 AstraZeneca Pharmaceuticals LP ($620.48)
2022 $840.53 41 AstraZeneca Pharmaceuticals LP ($357.96)
2021 $265.54 6 Vifor Pharma, Inc. ($204.85)
2020 $198.12 11 AstraZeneca Pharmaceuticals LP ($77.84)
2019 $917.97 51 Relypsa, Inc. ($271.70)
2018 $344.73 26 Fresenius USA Marketing, Inc. ($141.62)
2017 $202.78 4 Keryx Biopharmaceuticals, Inc. ($137.93)

All Payment Transactions

281 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/12/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $10.32 General
Category: Inflammation/Rare Disease
12/12/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $5.74 General
Category: Nephrology
12/03/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $19.19 General
Category: Nephrology
12/03/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $1.72 General
Category: Nephrology
12/03/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $0.70 General
Category: Nephrology
11/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $23.98 General
Category: Cardiovascular and Metabolism
11/19/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $18.90 General
Category: NEPHROLOGY
11/15/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $33.82 General
Category: Inflammation
10/29/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $25.63 General
Category: Cardiovascular and Metabolism
10/22/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $20.63 General
Category: Nephrology
10/18/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $19.51 General
Category: IMMUNOLOGY
10/09/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.50 General
Category: NEPHROLOGY
10/04/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $28.60 General
Category: IMMUNOLOGY
10/03/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $6.70 General
Category: Nephrology
10/01/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $27.59 General
Category: Cardiovascular and Metabolism
09/27/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $20.79 General
09/27/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $20.44 General
09/26/2024 Travere Therapeutics, Inc. Education In-kind items and services $3.08 General
09/25/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $28.53 General
Category: Nephrology
09/21/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $33.90 General
Category: Inflammation/Rare Disease
09/06/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $23.98 General
Category: Cardiovascular and Metabolism
08/22/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.98 General
Category: Cardiovascular and Metabolism
08/15/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $24.80 General
Category: Inflammation
08/14/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $29.55 General
Category: Nephrology
08/09/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.37 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 290 893 $325,212 $173,728
2022 8 325 1,054 $373,252 $199,668
2021 7 352 1,218 $387,061 $214,771
2020 6 287 654 $134,093 $75,538
Total Patients
1,254
Total Services
3,819
Medicare Billing
$663,705
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 36 292 $175,200 $90,738 51.8%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 28 98 $49,000 $25,386 51.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 65 239 $40,897 $25,207 61.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 79 165 $28,875 $17,836 61.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 46 60 $19,500 $9,224 47.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 23 23 $9,200 $4,327 47.0%
90935 Hemodialysis procedure with physician evaluation Facility 2023 13 16 $2,540 $1,009 39.7%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 39 333 $199,800 $105,231 52.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 85 354 $63,394 $32,167 50.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 73 91 $29,783 $15,835 53.2%
90966 Home dialysis services per month (20 years or older) Office 2022 12 60 $24,000 $15,690 65.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 62 131 $22,925 $14,156 61.8%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 19 45 $22,500 $11,762 52.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 18 18 $7,200 $3,406 47.3%
90935 Hemodialysis procedure with physician evaluation Facility 2022 17 22 $3,650 $1,420 38.9%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 44 383 $217,200 $122,403 56.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 110 496 $85,963 $45,646 53.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 76 106 $34,658 $18,972 54.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 64 135 $23,625 $15,324 64.9%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 14 19 $9,100 $5,009 55.0%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 28 63 $10,115 $4,114 40.7%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 16 16 $6,400 $3,302 51.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 80 352 $55,793 $33,133 59.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 70 87 $29,315 $15,785 53.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 71 133 $23,275 $12,736 54.7%

About Dr. Josephus-Ian Sanjorjo, MD

Dr. Josephus-Ian Sanjorjo, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1073808168.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Josephus-Ian Sanjorjo, MD has received a total of $5,622 in payments from pharmaceutical and medical device companies, with $1,297 received in 2024. These payments were reported across 281 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,376).

As a Medicare-enrolled provider, Sanjorjo has provided services to 1,254 Medicare beneficiaries, totaling 3,819 services with total Medicare billing of $663,705. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology, Hospitalist
  • Location Daly City, CA
  • Active Since 06/16/2011
  • Last Updated 02/07/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1073808168

Products in Payments

  • FARXIGA (Drug) $1,100
  • Veltassa (Drug) $699.88
  • Velphoro (Drug) $669.57
  • ACTHAR (Biological) $496.45
  • LOKELMA (Drug) $467.87
  • JYNARQUE (Drug) $278.92
  • KRYSTEXXA (Biological) $244.78
  • TARPEYO (Drug) $238.92
  • Parsabiv (Biological) $198.90
  • Kerendia (Drug) $178.99
  • Auryxia (Drug) $150.47
  • AURYXIA (Drug) $129.58
  • JARDIANCE (Drug) $103.85
  • Ozempic (Drug) $102.47
  • IBSRELA (Drug) $89.61
  • TAVNEOS (Drug) $77.19
  • Aranesp (Biological) $57.56
  • Edarbi (Drug) $45.88
  • JESDUVROQ (Drug) $40.30
  • INVOKANA (Drug) $20.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Daly City